Cytotoxic Chemotherapy as an Alternative for Systemic Treatment of Advanced Hepatocellular Carcinoma in Developing Countries

Systemic therapy options nowadays for advanced hepatocellular carcinoma (HCC) are either immunotherapy with immune checkpoint inhibitors or targeted therapy. As the incidence of liver cancer is much higher in developing countries, these new medications are not readily accessible for most of the pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Abouelezz, Khaled, Khanapara, Dipen, Batiha, Gaber El-Saber, Ahmed, Esraa A, Hetta, Helal F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707432/
https://www.ncbi.nlm.nih.gov/pubmed/33273860
http://dx.doi.org/10.2147/CMAR.S280631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707432/
https://www.ncbi.nlm.nih.gov/pubmed/33273860
http://dx.doi.org/10.2147/CMAR.S280631

Ejemplares similares